As defective mitochondrial homeostasis plays a pivotal role in the pathogenesis of AD, targeting mitochondrial dysfunction by offsetting the early accumulation of APP may be a promising therapeutic intervention for AD [45]. Here, APP is linked to Alzheimer disease.